Table 2.

Association between study DHA intake and pre intervention values with the post intervention status of fatty acids and functional outcomes; outcomes were regressed on DHA intake and corresponding pre study value, R² corresponds to the percentage of outcome variance explained by the regressors (DHA intake and pre value), significant associations (p < 0.01) are printed in bold.

	n	R2	Stand. β for DHA Intake	p	Stand. β for Pre Value	p
LOS T-score	78	40	−0.016	0.857	0.644	4.0 × 10−10
RPM-score	80	64	−0.108	0.118	0.808	5.0 × 10−19
VEP15 (ms)	74	57	−0.027	0.727	0.764	8.2 × 10−15
DHA-%	82	66	0.653	7.5 × 10−16	0.532	3.4 × 10−12
DHA (mg/L)	82	63	0.614	7.4 × 10−14	0.551	4.9 × 10−12
LDL/HDL	71	55	−0.055	0.495	0.749	7.4 × 10−14
Chol. (mmol/L)	76	38	0.109	0.239	0.602	7.5 × 10−9
TG (mmol/L)	79	33	0.049	0.601	0.59	1.3 × 10−8
LA (mg/L)	82	32	0.144	0.121	0.556	4.5 × 10−8
ALA (mg/L)	82	32	−0.006	0.948	0.577	2.4 × 10−8
ARA (mg/L)	82	29	−0.118	0.215	0.526	3.3 × 10−7